We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
(+27%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 2 |
Apple
AAPL
|
+$74.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$68.1M |
| 4 |
Tesla
TSLA
|
+$64.9M |
| 5 |
Microsoft
MSFT
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$12.3M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.37M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$7.53M |
| 4 |
ASML
ASML
|
+$7.05M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$6.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.81% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 11.37% |
| 4 | Energy | 7.72% |
| 5 | Consumer Discretionary | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Arcturus Therapeutics
ARCT
$171M
| $3.55M | 0.03% |
209,254
-51,726
| -20% | -$902K |
|
452
Simon Property Group
SPG
$74.3B
| $3.5M | 0.03% |
29,783
+10,363
| +53% | +$1.15M |
|
453
Emerson Electric
EMR
$86.7B
| $3.49M | 0.03% |
36,383
+17,559
| +93% | +$1.58M |
|
454
Etsy
ETSY
$7.89B
| $3.44M | 0.03% |
28,730
+2,416
| +9% | +$276K |
|
455
Viridian Therapeutics
VRDN
$2.13B
| $3.42M | 0.03% |
117,013
+59,222
| +102% | +$1.36M |
|
|
ACLX
456
DELISTED
Arcellx
ACLX
| $3.41M | 0.03% |
110,218
+17,765
| +19% | +$407K |
|
457
VICI Properties
VICI
$29.2B
| $3.37M | 0.03% |
104,123
+24,822
| +31% | +$797K |
|
458
Hewlett Packard
HPE
$66.5B
| $3.36M | 0.03% |
210,382
+36,875
| +21% | +$544K |
|
459
Dominion Energy
D
$60.5B
| $3.33M | 0.03% |
54,342
+23,412
| +76% | +$1.47M |
|
460
FedEx
FDX
$73.2B
| $3.32M | 0.03% |
19,168
+8,618
| +82% | +$1.43M |
|
|
ROCC
461
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.29M | 0.03% |
81,478
-3,898
| -5% | -$154K |
|
|
ICPT
462
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.29M | 0.03% |
265,917
+40,313
| +18% | +$571K |
|
463
HEICO Corp Class A
HEI.A
$36.6B
| $3.29M | 0.03% |
27,417
+5,675
| +26% | +$693K |
|
464
AutoZone
AZO
$48.8B
| $3.28M | 0.03% |
1,330
+466
| +54% | +$1.13M |
|
465
IQVIA
IQV
$38.4B
| $3.27M | 0.03% |
15,983
+6,021
| +60% | +$1.22M |
|
466
Regenxbio
RGNX
$638M
| $3.25M | 0.03% |
143,247
+26,140
| +22% | +$591K |
|
467
General Motors
GM
$79.3B
| $3.25M | 0.03% |
96,509
+32,636
| +51% | +$1.21M |
|
468
Protagonist Therapeutics
PTGX
$8.51B
| $3.22M | 0.03% |
295,348
-51,587
| -15% | -$435K |
|
469
Ocugen
OCGN
$423M
| $3.21M | 0.03% |
2,471,170
+537,263
| +28% | +$837K |
|
470
Okta
OKTA
$24.6B
| $3.2M | 0.03% |
46,813
-110,267
| -70% | -$6.3M |
|
471
Paycom
PAYC
$7.86B
| $3.19M | 0.03% |
10,296
+1,284
| +14% | +$414K |
|
472
Sempra
SRE
$57.3B
| $3.17M | 0.03% |
40,968
+17,588
| +75% | +$1.36M |
|
473
Keros Therapeutics
KROS
$200M
| $3.16M | 0.03% |
65,816
+8,519
| +15% | +$398K |
|
474
Ford
F
$57.5B
| $3.14M | 0.03% |
269,839
+98,301
| +57% | +$1.26M |
|
475
VeriSign
VRSN
$27B
| $3.1M | 0.03% |
15,096
-35,832
| -70% | -$6.87M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.
- Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
- Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
- Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
- Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
- Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.
Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.